In a study of liver fibrosis, liver fibrosis can be significantly attenuated by exogenous administration of Alda-1 by up-regulating the antioxidant Nrf2/HO-1 pathway and activating Parkin-related mitophagy (60). The gene discussed is PRKN; the disease is Hepatic fibrosis.